Tag: Enliven Therapeutics
Enliven Therapeutics, Inc. ($ELVN) Initiates Underwritten Common Stock Sale
Enliven Therapeutics, Inc. (Nasdaq: ELVN) has initiated an underwritten public offering of $200 million worth of its common stock shares. The company is offering...